{"id":"https://openalex.org/W4416088153","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","title":"609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma","display_name":"609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4416088153","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0609"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0609","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A694.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/13/Suppl_2/A694.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089670001","display_name":"Debashis Sarker","orcid":"https://orcid.org/0000-0003-4814-8429","observed_orcids":["https://orcid.org/0000-0003-4814-8429","https://orcid.org/0000-0001-6948-2974"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Debashis Sarker","raw_affiliation_strings":["Guy\u2019s Hospital, King\u2019s College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guy\u2019s Hospital, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Georgina Long","raw_affiliation_strings":["The University of Sydney, Syndey, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Sydney, Syndey, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001343667","display_name":"David James Pinato","orcid":"https://orcid.org/0000-0002-3529-0103","observed_orcids":["https://orcid.org/0000-0002-3529-0103"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David J Pinato","raw_affiliation_strings":["Imperial College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112390975","display_name":"Adnan Khattak","orcid":"https://orcid.org/0000-0002-4633-3818","observed_orcids":["https://orcid.org/0000-0002-4633-3818","https://orcid.org/0009-0008-2954-119X"]},"institutions":[{"id":"https://openalex.org/I12079687","display_name":"Edith Cowan University","ror":"https://ror.org/05jhnwe22","country_code":"AU","type":"education","lineage":["https://openalex.org/I12079687"]},{"id":"https://openalex.org/I2800639565","display_name":"Hollywood Private Hospital","ror":"https://ror.org/0101aa973","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800639565"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adnan Khattak","raw_affiliation_strings":["Hollywood Private Hospital and Edith Cowan University, Perth, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hollywood Private Hospital and Edith Cowan University, Perth, WA, Australia","institution_ids":["https://openalex.org/I12079687","https://openalex.org/I2800639565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029723783","display_name":"Theresa Michelle Medina","orcid":"https://orcid.org/0000-0003-0579-4121","observed_orcids":["https://orcid.org/0000-0003-0579-4121"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theresa Medina","raw_affiliation_strings":["University of Colorado, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Aurora, CO, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026686211","display_name":"Ioannis Karydis","orcid":"https://orcid.org/0000-0002-8308-3141","observed_orcids":["https://orcid.org/0000-0002-8308-3141"]},"institutions":[{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]},{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ioannis Karydis","raw_affiliation_strings":["University Hospital Southampton NHS Trust and University of Southampton, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Southampton NHS Trust and University of Southampton, Southampton, UK","institution_ids":["https://openalex.org/I2802965805","https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037541807","display_name":"Gary Middleton","orcid":"https://orcid.org/0000-0001-5695-3474","observed_orcids":["https://orcid.org/0000-0001-5695-3474"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gary William Middleton","raw_affiliation_strings":["University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK","institution_ids":["https://openalex.org/I1308923049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033684622","display_name":"Pavlina Spiliopoulou","orcid":"https://orcid.org/0000-0002-6486-6319","observed_orcids":["https://orcid.org/0000-0002-6486-6319"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Pavlina Spiliopoulou","raw_affiliation_strings":["School of Cancer Sciences, University of Glasgow, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences, University of Glasgow, Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026494264","display_name":"Anjali Rohatgi","orcid":"https://orcid.org/0009-0009-9793-913X","observed_orcids":["https://orcid.org/0009-0009-9793-913X"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjali Rohatgi","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102845964","display_name":"Martin E Gutierrez","orcid":"https://orcid.org/0000-0002-3642-2315","observed_orcids":["https://orcid.org/0000-0002-3642-2315"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Gutierrez","raw_affiliation_strings":["Hackensack University Medical Center, Ridgewood, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hackensack University Medical Center, Ridgewood, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018322482","display_name":"ADIL I. DAUD","orcid":"https://orcid.org/0000-0002-6617-8421","observed_orcids":["https://orcid.org/0000-0002-6617-8421"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adil Daud","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020352800","display_name":"Valentina Boni","orcid":"https://orcid.org/0000-0002-8675-0018","observed_orcids":["https://orcid.org/0000-0002-8675-0018"]},"institutions":[{"id":"https://openalex.org/I4210109886","display_name":"Hospital Universitario Quir\u00f3nsalud Madrid","ror":"https://ror.org/018q88z15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210109886"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Valentina Boni","raw_affiliation_strings":["NEXT Madrid, Universitario Hospital Quiron Salud, Pozuelo de Alarc\u00f3n, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEXT Madrid, Universitario Hospital Quiron Salud, Pozuelo de Alarc\u00f3n, Madrid, Spain","institution_ids":["https://openalex.org/I4210109886"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark R Middleton","raw_affiliation_strings":["University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073289880","display_name":"Randy F. Sweis","orcid":"https://orcid.org/0000-0002-0497-9637","observed_orcids":["https://orcid.org/0000-0002-0497-9637"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randy F Sweis","raw_affiliation_strings":["University of Chicago, Medicine, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Medicine, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073246708","display_name":"Julie E. Bauman","orcid":"https://orcid.org/0000-0002-1398-6636","observed_orcids":["https://orcid.org/0000-0002-1398-6636"]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie E Bauman","raw_affiliation_strings":["George Washington University Cancer Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George Washington University Cancer Center, Washington, DC, USA","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070212769","display_name":"Sarah J. Danson","orcid":"https://orcid.org/0000-0002-3593-2890","observed_orcids":["https://orcid.org/0000-0002-3593-2890"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Danson","raw_affiliation_strings":["University of Sheffield, Sheffield Teaching Hospital NHS Trust, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Sheffield, Sheffield Teaching Hospital NHS Trust, Sheffield, UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jacky Chow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108601","display_name":"Moderna Therapeutics (United States)","ror":"https://ror.org/01xm4wg91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacky Chow","raw_affiliation_strings":["Moderna, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210108601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101980871","display_name":"Jingting Xu","orcid":"https://orcid.org/0000-0002-4644-0170","observed_orcids":["https://orcid.org/0000-0002-4644-0170"]},"institutions":[{"id":"https://openalex.org/I4210108601","display_name":"Moderna Therapeutics (United States)","ror":"https://ror.org/01xm4wg91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingting Xu","raw_affiliation_strings":["Moderna, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210108601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077094167","display_name":"Hikmat N. Daghestani","orcid":"https://orcid.org/0009-0000-0366-5444","observed_orcids":["https://orcid.org/0009-0000-0366-5444","https://orcid.org/0000-0001-7851-6574"]},"institutions":[{"id":"https://openalex.org/I4210108601","display_name":"Moderna Therapeutics (United States)","ror":"https://ror.org/01xm4wg91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hikmat N Daghestani","raw_affiliation_strings":["Moderna, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210108601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147179534","display_name":"Michael Abadier","orcid":"https://orcid.org/0009-0002-9201-2502","observed_orcids":["https://orcid.org/0009-0002-9201-2502"]},"institutions":[{"id":"https://openalex.org/I4210108601","display_name":"Moderna Therapeutics (United States)","ror":"https://ror.org/01xm4wg91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Abadier","raw_affiliation_strings":["Moderna, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210108601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan J Sullivan","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":20,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A694","last_page":"A694"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7009999752044678},{"id":"https://openalex.org/keywords/ido1","display_name":"IDO1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9819999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.8510000109672546},{"id":"https://openalex.org/keywords/refractory-melanoma","display_name":"refractory melanoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/t-cell-receptor-clonality","display_name":"T-cell receptor clonality","score":0.8199999928474426},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-infiltrating-macrophages","display_name":"tumor-infiltrating macrophages","score":0.5989999771118164},{"id":"https://openalex.org/keywords/tumor-infiltrating-neutrophils","display_name":"tumor-infiltrating neutrophils","score":0.6579999923706055},{"id":"https://openalex.org/keywords/tumor-infiltrating-b-cells","display_name":"tumor-infiltrating B cells","score":0.5720000267028809},{"id":"https://openalex.org/keywords/ctdna","display_name":"ctDNA","score":0.49000000953674316},{"id":"https://openalex.org/keywords/immune-reconstitution","display_name":"immune reconstitution","score":0.4099999964237213},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9107999801635742},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6593999862670898},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5828999876976013},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5149999856948853},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5105000138282776},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.47999998927116394},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4025999903678894},{"id":"https://openalex.org/C169382597","wikidata":"https://www.wikidata.org/wiki/Q21208025","display_name":"Programmed cell death 1","level":5,"score":0.3716000020503998},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2879999876022339},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.2782000005245209},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2685000002384186},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.26030001044273376},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2556999921798706},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25369998812675476}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2025-sitc2025.0609","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A694.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/6c71c6f4-9a67-4c1a-8f8a-c00206fc7e12","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/6c71c6f4-9a67-4c1a-8f8a-c00206fc7e12","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0609","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0609","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A694.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9969000220298767,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319071","display_name":"Moderna","ror":"https://ror.org/01xm4wg91"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416088153.pdf","grobid_xml":"https://content.openalex.org/works/W4416088153.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415940391","https://openalex.org/W7117295617","https://openalex.org/W7154697590","https://openalex.org/W4402560078","https://openalex.org/W4379283316","https://openalex.org/W4409624268","https://openalex.org/W2741276440","https://openalex.org/W7161599392","https://openalex.org/W4401422221","https://openalex.org/W4308383972"],"abstract_inverted_index":{"Background":[0],"mRNA-4359":[1,34,64,88,362],"is":[2],"an":[3,68,124,300],"investigational":[4],"immunotherapy":[5],"designed":[6],"to":[7,99,189,244,314,329,346],"activate":[8],"antigen-specific":[9,113,374],"T":[10,114,117,168,194,315,342,359,375,390],"cells":[11],"that":[12],"target":[13],"both":[14,202],"PD-L1":[15,290],"and":[16,21,28,50,103,108,121,149,235,266,291,318,351,357,382,410,444],"IDO1":[17,292],"expressed":[18],"by":[19,372,404,415],"tumor":[20,31,51,104,275,305],"immunosuppressive":[22],"cells.":[23],"By":[24],"promoting":[25],"T-cell":[26],"responses":[27,170],"reshaping":[29],"the":[30,37,263,416,437,440,445],"microenvironment":[32],"(TME),":[33],"may":[35,365],"enhance":[36],"efficacy":[38],"of":[39,74,123,136,154,180,191,210,222,289,396,439,442],"immune":[40,301,367],"checkpoint":[41,55,397],"blockade":[42],"in":[43,175,178,217,224,228,232,237,257,273,295,309,325,341,369,434],"resistant":[44],"settings.":[45],"Here,":[46],"we":[47],"present":[48],"peripheral":[49],"translational":[52],"data":[53],"from":[54],"inhibitor":[56,398],"resistant/refractory":[57],"(CPI-R/R)":[58],"melanoma":[59,80,371],"patients":[60,77],"(pts)":[61],"treated":[62],"with":[63,78,131,182,219,283,299,331,349,388,436],"plus":[65,87,363],"pembrolizumab.Methods":[66],"In":[67],"ongoing":[69],"trial":[70],"(":[71],"NCT05533697),":[72],"as":[73],"28Feb2025,":[75],"29":[76],"CPI-R/R":[79,370],"received":[81],"pembrolizumab":[82,364],"(400":[83,89],"mg":[84],"IV":[85],"Q6W)":[86],"\u00b5g":[90,94],"[n=14]":[91],"or":[92,166,333,421],"1000":[93],"[n=15]":[95],"IM,":[96],"Q3W,":[97],"up":[98,243],"9":[100,160],"doses.":[101],"Peripheral":[102,164],"samples":[105,184,306],"collected":[106],"pre-":[107],"on-treatment":[109],"were":[110,129,171,254,322,413],"analyzed":[111],"for":[112,355,394],"cell":[115,118,169,195,316,343,391],"responses,":[116],"clonality,":[119],"ctDNA,":[120],"features":[122],"immune-inflamed":[125,310],"TME.Results":[126],"Twenty-five":[127],"pts":[128,181,282,330],"response-evaluable":[130],"objective":[132],"response":[133],"rate":[134,152],"(ORR)":[135],"24%":[137],"(n":[138],"=":[139],"6,":[140],"1":[141],"complete":[142],"responder,":[143],"CR;":[144],"5":[145],"partial":[146],"responders,":[147,218,296],"PR)":[148],"disease":[150,239],"control":[151],"(DCR)":[153],"60%":[155],"(n=15:":[156],"6":[157],"ORRs":[158],"+":[159],"stable":[161],"disease,":[162],"SD).":[163],"PD-L1-":[165],"IDO1-specific":[167],"detected":[172,256],"post-treatment":[173],"after":[174,262],"vitro":[176],"expansion":[177],"majority":[179],"evaluable":[183],"(11/16,":[185],"69%).":[186],"Treatment":[187],"led":[188],"increases":[190,308,340],"novel":[192,211],"expanded":[193,212,251],"receptor":[196],"(TCR)":[197],"clones":[198,214,253],"over":[199],"time":[200],"across":[201],"dose":[203],"groups":[204],"(n=23).":[205],"The":[206,408,430],"median":[207],"peak":[208],"number":[209],"TCR":[213,252,380],"was":[215,293,402,432],"higher":[216,294,324,353],"clone":[220],"counts":[221],"82":[223],"CR":[225],"(n=1),":[226],"67":[227],"PR":[229,326],"(n=5),":[230],"24":[231],"SD":[233,332],"(n=8),":[234],"22":[236],"progressive":[238],"(PD,":[240],"n=9),":[241],"assessed":[242],"269":[245],"days":[246],"post-treatment.":[247],"A":[248],"few":[249],"peripherally":[250],"also":[255],"responder":[258],"tumors":[259],"3":[260],"weeks":[261],"first":[264],"dose,":[265],"most":[267],"responders":[268],"(4/5)":[269],"show":[270],">95%":[271],"reduction":[272],"ctDNA":[274],"methylation":[276],"score":[277],"at":[278,425],"week":[279],"6.Among":[280],"23":[281],"baseline":[284],"biopsy,":[285],"dual":[286],"gene":[287,311],"expression":[288],"which":[297,321],"correlated":[298],"inflamed":[302,386],"phenotype.":[303],"On-treatment":[304],"showed":[307],"signatures":[312],"related":[313],"inflammation":[317],"antigen":[319],"presentation,":[320],"\u22652-fold":[323],"(n=4)":[327,337],"compared":[328,345],"PD":[334],"(n=11).":[335],"Responders":[336],"exhibited":[338],"greater":[339],"infiltration":[344],"non-responders":[347],"(n=11),":[348],"6.2-fold":[350],"1.9-fold":[352],"levels":[354],"CD4":[356],"CD8":[358],"cells,":[360,376],"respectively.Conclusions":[361],"restore":[366],"responsiveness":[368],"priming":[373],"expanding":[377],"de":[378],"novo":[379],"clones,":[381],"creating":[383],"a":[384],"more":[385],"TME":[387],"increased":[389],"infiltration,":[392],"allowing":[393],"restoration":[395],"response.Acknowledgements":[399],"This":[400],"study":[401,428,431],"funded":[403],"Moderna,":[405],"Inc.Ethics":[406],"Approval":[407],"protocol":[409],"all":[411],"amendments":[412],"approved":[414],"appropriate":[417],"institutional":[418],"review":[419],"board":[420],"independent":[422],"ethics":[423],"committee":[424],"each":[426],"participating":[427],"site.":[429],"conducted":[433],"accordance":[435],"principles":[438],"Declaration":[441],"Helsinki":[443],"International":[446],"Conference":[447],"on":[448],"Harmonization":[449],"Good":[450],"Clinical":[451],"Practice":[452],"guidelines.":[453]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2025-11-10T00:00:00"}